Adalimumab drug levels at secondary loss of response in Crohn's disease; are we aiming high enough? A retrospective, international multi-centre study

被引：0
|
作者：
Swaine, A. [1 ]
Reynolds, R. [2 ]
Roblin, X. [3 ]
Gibson, D. [1 ]
Martin, C. [4 ]
Irving, P. [2 ]
Sparrow, M. [1 ]
Ward, M. [1 ]
机构：
[1] Alfred Hosp, Gastroenterol, Melbourne, Vic, Australia
[2] Guys & St Thomas Trust, Gastroenterol, London, England
[3] CHU St Etienne, Gastroenterol, St Etienne, France
[4] Monash Univ, Epidemiol & Preventat Med, Melbourne, Vic, Australia
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P706
引用
收藏
页码：S571 / S572
页数：3
相关论文
共 50 条
  • [21] Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease
    Mazor, Y.
    Almog, R.
    Kopylov, U.
    Ben Hur, D.
    Blatt, A.
    Dahan, A.
    Waterman, M.
    Ben-Horin, S.
    Chowers, Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (06) : 620 - 628
  • [22] An open label study of adalimumab in Crohn's disease patients with a loss of response to infliximab
    Anwar, Malik
    O'Sullivan, Maria
    Ryan, Barbara
    Breslin, Niall
    O'Connor, Humphrey
    O'Morain, Colm
    GASTROENTEROLOGY, 2006, 130 (04) : A662 - A662
  • [23] Segmental vs extended colectomy for colorectal cancer in Crohn's Disease: Results from a multi-centre retrospective comparative study
    Sensi, B.
    Khan, J.
    Janindra, W.
    Siragusa, L.
    Panis, Y.
    Frontali, A.
    Stefan, S.
    Bellato, V.
    Espin Basany, E.
    Marti-Gallostra, M.
    Frasson, M.
    Garcia Granero, E.
    Spinelli, A.
    Carvello, M.
    Sampietro, G.
    Fichera, A.
    Artigue, M.
    Zaghiyan, K.
    Adams, E.
    Konishi, T.
    Pellino, G.
    Sica, G.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S068 - S069
  • [24] COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE: MULTI-CENTRE RETROSPECTIVE COHORT STUDY
    Townsend, Tristan
    Razanskaite, Violeta
    Michail, Stephanie
    Morgan, James
    Davies, Michael
    Storey, Daniel
    Watters, Christopher
    Penman, Douglas
    Swaminathan, Mira
    Reilly, Ian
    Flanagan, Paul
    Subramanian, Sreedhar
    GUT, 2021, 70 : A127 - A127
  • [25] Higher anti-tumour necrosis factor-alpha drug levels are associated with improved radiological outcomes in patients with perianal fistulising Crohn's disease: A retrospective multi-centre study
    De Gregorio, M.
    Lee, T.
    Krishnaprasad, K.
    Amos, G.
    An, Y. K.
    Bastian-Jordan, M.
    Begun, J.
    Borok, N.
    Brown, D. J. M.
    Cheung, W.
    Connor, S.
    Gerstenmaier, J.
    Gilbert, Li
    Gilmore, R.
    Gu, B.
    Kutaiba, N.
    Lee, A.
    Mahy, G.
    Srinivasan, A.
    Thin, L.
    Thompson, A.
    Welman, C. J.
    Yong, E. X.
    De Cruz, P.
    van Langenberg, D.
    Sparrow, M.
    Ding, N. S.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S408 - S408
  • [26] Evaluating Adalimumab Drug and Antibody Levels As Predictors of Clinical and Laboratory Response in Crohn's Disease Patients
    Mazor, Yoav
    Kopylov, Uri
    Ben Hur, Dana
    Almog, Ronit
    Waterman, Matti
    Ben-Horin, Shomron
    Chowers, Yehuda
    GASTROENTEROLOGY, 2013, 144 (05) : S778 - S778
  • [27] EVALUATION OF PREDICTORS OF DURABLE CLINICAL RESPONSE TO INFLIXIMAB AFTER SECONDARY LOSS OF RESPONSE TO ADALIMUMAB AMONG PATIENTS WITH CROHN'S DISEASE
    Younis, Adam
    Barnes, Edward L.
    Herfarth, Hans H.
    GASTROENTEROLOGY, 2019, 156 (06) : S1139 - S1140
  • [28] Effectiveness and safety of Ustekinumab for induction of remission in patients with Crohn's disease: a multi-centre Israeli study
    Shitrit, A. Bar-Gil
    Siterman, M.
    Waterman, M.
    Hirsh, A.
    Khoury, T.
    Schwartz, D.
    Zittan, E.
    Adler, J.
    Koslowsky, B.
    Avni-Biron, I.
    Chowers, Y.
    Ron, Y.
    Israeli, E.
    Ungar, B.
    Yanai, H.
    Maharshak, N.
    Ben-Horin, S.
    Ben-Ya'acov, A.
    Eliakim, R.
    Dotan, I.
    Goldin, E.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S399 - S400
  • [29] Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease: a multi-centre retrospective cohort study
    Townsend, T.
    Razanskaite, V.
    Michail, S.
    Morgan, J.
    Davies, M.
    Storey, D.
    Watters, C.
    Penman, D.
    Swaminathan, M.
    Sabine, J.
    Chapman, A.
    Vyas, A.
    Reilly, I.
    Flanagan, P.
    Bodger, K.
    Subramanian, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S407 - S408
  • [30] Strategy of selecting anti-TNF agent in patients with Crohn's disease: A multi-centre retrospective cohort study by the Osaka gut forum
    Amano, T.
    Shinzaki, S.
    Tashiro, T.
    Otake, Y.
    Tani, M.
    Yoshihara, T.
    Iwatani, S.
    Tsujii, Y.
    Inoue, T.
    Hayashi, Y.
    Iijima, H.
    Takehara, T.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S551 - S551
12345